• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Infectious Disease

Policy statement outlines recommendations on management of infants born to mothers with COVID-19

byMichael DinhandLeah Carr, MD
April 6, 2020
in Infectious Disease, Obstetrics, Pediatrics, Public Health
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. The American Academy of Pediatrics (AAP) recommends that newborns born to mothers affected by or being tested for COVID-19 be temporarily separated from their mothers. It is also recommended that these infants be separated from newborns born to unaffected mothers in order to reduce risk of transmission.

2. The report also recommends that for infants requiring evaluation at sites with available testing, molecular assays should be completed at 24 hours of life and then repeated at 48 hours. The AAP statement also includes recommendations for feeding with breast milk obtained by pumping adherent to cleaning protocols.

Statement Rundown: As the novel coronavirus SARS-CoV-2 and the disease it causes, COVID-19, continue to spread globally, limited data have been available regarding its transmission between pregnant women and newborns. The American Academy of Pediatrics (AAP) has published a report offering interim guidance for infants born to mothers with confirmed or suspected COVID-19. Key recommendations of this statement are listed below:

  • Thus far, studies and case reports have documented COVID-19 in children as young as 2 days of age, and while pediatric cases are generally less severe than cases in older individuals, a number of infants have been reported to have severe or critical illness.
  • Current evidence is insufficient to understand the potential for vertical transmission. The AAP recommends that neonates born to women with or being tested for COVID-19 should be considered as persons under investigation for the virus as well, and that proper droplet and contact precautions should be used for encounters. In addition, airborne precautions should be observed in situations with potential for the generation of aerosols. It is acknowledged that certain centers’ shortages of personal protective equipment may limit if individuals can follow this recommendation.
  • Mothers and newborns should be separated to minimize the risk of postnatal infant infection. The likely benefits of separation should be discussed with mothers prior to delivery.
  • Infants born to mothers with or being tested for COVID-19 should ideally be admitted to specific areas separate from areas for newborns unaffected by maternal COVID-19. Should an infant require neonatal intensive care, they should optimally be admitted to a single patient room with negative room pressure capabilities. Separation in the hospital should be maintained until the mother has been a) afebrile for 72 hours without the use of antipyretics, and b) at least 7 days have passed since symptoms first appeared.
  • No study to date has demonstrated the presence of SARS-CoV-2 in breast milk, so breast milk expression and feeding should continue with appropriate cleaning of breast pumps and components.
  • Should a mother choose to room-in with her infant, the infant should remain at least 6 feet from the mother at all times. If the mother requests skin-to-skin contact, she should wear a mask and ensure breast hygiene.
  • Newborns born to COVID-19-affected mothers should be tested at 24 and 48 hours of age. If two tests obtained at least 24 hours apart are negative, the hospital may transition the infant to universal precautions.
  • Infants testing positive but not displaying symptoms may be discharged home on a case-by-case basis with appropriate precautions and plans for follow-up, ideally not to individuals >60 years of age or those with underlying health conditions. Infants testing negative can be discharged home to the care of a healthy caregiver.

Click to read the policy statement, published in Pediatrics

Click to read the accompanying FAQ

Relevant reading: Interim Considerations for Infection Prevention and Control of Coronavirus Disease 2019 (COVID-19) in Inpatient Obstetric Healthcare Settings

Image: PD

RELATED REPORTS

SAR-CoV-2 infection during pregnancy may lead to adverse neurodevelopmental outcomes in male offspring

Past infection with pre-omicron variants of COVID-19 protects against re-infection

Symptom and viral relapse more common in COVID-19 patients without antiviral treatment

©2020 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: breastfeedingCoronavirusinfantsneonatesneonatologySARS-CoV-2skin-to-skin
Previous Post

Epidemiologic features of the 2018-2019 measles outbreak in New York City

Next Post

Type of e-cigarette impacts risk of subsequent cigarette smoking

RelatedReports

Paternal factors associated with short interpregnancy interval
Infectious Disease

SAR-CoV-2 infection during pregnancy may lead to adverse neurodevelopmental outcomes in male offspring

March 29, 2023
Decreased expression of nasal ACE2 may be correlated with lower prevalence of COVID-19 in children
Chronic Disease

Past infection with pre-omicron variants of COVID-19 protects against re-infection

March 28, 2023
Decreased expression of nasal ACE2 may be correlated with lower prevalence of COVID-19 in children
Chronic Disease

Symptom and viral relapse more common in COVID-19 patients without antiviral treatment

March 21, 2023
Emergency

Different variants presenting with different presentations amongst children with COVID-19 infections

March 13, 2023
Next Post
Smoking during pregnancy associated with aerobic fitness of children

Type of e-cigarette impacts risk of subsequent cigarette smoking

Assessment of Combined Nivolumab and Bevacizumab in Relapsed Ovarian Cancer: A Phase 2 Clinical Trial

2 Minute Medicine Rewind April 6, 2020

PCSK9 inhibitors unlikely to be cost-effective

Insclisiran significantly decreases LDL cholesterol in heterozygous familial hypercholesterolemia patients

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • SAR-CoV-2 infection during pregnancy may lead to adverse neurodevelopmental outcomes in male offspring
  • Hyperfractionated radiotherapy reduces complication rates compared to standard fractionation for locally advanced nasopharyngeal carcinoma
  • Lebrikizumab effective in treating moderate-to-severe atopic dermatitis
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options